Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder
Álex Iranzo, Angela Mammana, Amaia Muñoz‐Lopetegi, et al.
Neurology (2023) Vol. 100, Iss. 18
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review
Eva Schaeffer, Rezzak Yılmaz, Erik K. St. Louis, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S307-S319
Open Access | Times Cited: 5
Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series
Gerard Mayà, Álex Iranzo, Carles Gaig, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 12, pp. 1238-1251
Closed Access | Times Cited: 5
REM sleep behaviour disorder (RBD): Personal perspectives and research priorities
Carlos H. Schenck
Journal of Sleep Research (2024)
Closed Access | Times Cited: 4
CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder
Amaia Muñoz‐Lopetegi, Simone Baiardi, Mircea Balasa, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Seeding activity of skin misfolded tau as a biomarker for tauopathies
Zerui Wang, Ling Wu, Maria Gerasimenko, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Advancing Parkinson’s diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples
Elizabeth Carrazana, Leonardo Montalbán-Gutiérrez, Pedro Chaná‐Cuevas, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Detection of alpha synuclein seeding activity in tear fluid in patients with Parkinson's disease
Sezgi Canaslan, Matthias Schmitz, Fabian Maass, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Prodromal Parkinson’s Disease
Iro Boura, Karolina Popławska-Domaszewicz, Naomi Limbachiya, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 209-228
Closed Access
Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease
David Bendetowicz, Vincent Planche, Erwan Bézard, et al.
Journal of Parkinson s Disease (2025)
Open Access
Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
James A. Wiseman, Clinton Turner, Richard L. M. Faull, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease
Ambra Stefani, Elena Antelmi, Dario Arnaldi, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access
Sleep and Prodromal Synucleinopathies
Johnson D. Pounders, Stuart J. McCarter
Seminars in Neurology (2025)
Closed Access
A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Clinics and Practice (2025) Vol. 15, Iss. 3, pp. 65-65
Open Access
The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New Lexicon
Dario Arnaldi, Pietro Mattioli, Beatrice Orso, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 4
Open Access
Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track?
Kristína Kulcsarová, Matěj Škorvánek
Movement Disorders (2024) Vol. 39, Iss. 4, pp. 637-643
Closed Access | Times Cited: 3
Concerns with the new biological research criteria for synucleinopathy
Bradley F. Boeve, Albert A. Davis, Yo‐El S. Ju, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 7, pp. 659-660
Closed Access | Times Cited: 3
Developing disease-modifying interventions in idiopathic REM sleep behavior disorder and early synucleinopathy
Dario Arnaldi, Alex Iranzo, Flavio Nobili, et al.
Parkinsonism & Related Disorders (2024) Vol. 125, pp. 107042-107042
Closed Access | Times Cited: 3
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies
Annika Kluge, Alex Iranzo
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S323-S331
Open Access | Times Cited: 3
Immune landscape of the enteric nervous system differentiates Parkinson's disease patients from controls: The PADUA-CESNE cohort
Marta Campagnolo, Luca Weis, Michele Sandre, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106609-106609
Open Access | Times Cited: 3
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation
Yaoyun Kuang, Hengxu Mao, Xiaoyun Huang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Detection of a Parkinson's Disease–Specific MicroRNA Signature in Nasal and Oral Swabs
Patricia Schließer, Felix L. Struebing, Bernd H. Northoff, et al.
Movement Disorders (2023) Vol. 38, Iss. 9, pp. 1706-1715
Open Access | Times Cited: 7
Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
Zerui Wang, Ling Wu, Maria Gerasimenko, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson’s Disease
Andrea Pilotto, Gianluigi Zanusso, Elena Antelmi, et al.
Journal of Parkinson s Disease (2024), pp. 1-12
Open Access | Times Cited: 2
Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson’s disease
Hengxu Mao, Yaoyun Kuang, Feng Du, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Fluid and tissue biomarkers in Parkinson’s disease: Immunodetection or seed amplification? Central or peripheral?
Cèlia Painous, Manel Fernández, J. Pérez Pérez, et al.
Parkinsonism & Related Disorders (2023) Vol. 121, pp. 105968-105968
Closed Access | Times Cited: 5

Scroll to top